C21 · Pharmaceuticals · Global
High GDP developed countries medicine spending growth
Global: 155.1 billion constant USD in 2026–2030.
- Irregular Release cadence
- 1 Record · 1 region · 2026–2030
Verified 27 Sep 2026 · 1 publisher
The figure
One published observation so far. A chart follows as soon as a second period is published.
High GDP developed countries medicine spending growth
Global, 2026–2030
Every record
1 record · 1 region · 2026–2030. Each period links to its record: the value, its source evidence and original document.
Download this data
Every file carries its provenance: the CSV has a source column per row, and the chart images print the publisher, the licence and this page's address under the drawing. Source: IQVIA. Licence: CC BY 4.0.
Use and publication rights
- View, cite and link: free
Quote any number, cite this page or a single record, and link to it anywhere.
- Copy, chart and republish: free with attribution
The data is published under CC BY 4.0, commercial use included. Credit StatOrigin and the original publisher (IQVIA); the chart files already carry that line.
- The source documents: the publisher's terms
Figures are facts read from the publishers' own documents. The documents themselves, their text and design, stay under each publisher's terms; follow the source links for those.
How this measure is built
- Definition
- Projected medicine spending growth for a group of 14 larger high GDP countries excluding the United States.
- Measure
- One slice of Medicine spending ( form: growth ) . Total expenditure on pharmaceutical products and therapies. Region and period are columns on every record, not slices.
- Limitations
- 1 figure is a projection, drawn dashed and labelled in the table. Values are shown as published; StatOrigin does not revise, fill gaps or convert currencies.
- Verification
- Each value, unit, period and place was checked against its source evidence before publication. See the methodology and the corrections process.
Sources · 1 document
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Global Medicine Use Trends 2026 | IQVIA | — | 1 |
Other slices of medicine spending
- Cell and gene therapy spending share by geography 2 cell and gene therapy
- Net medicine spending 2 net prices
- Net medicine spending growth rate 2 net prices
- Oncology medicine spending at list prices 2 list prices · oncology
- COVID-19 vaccines and therapeutics spending decline 1 covid 19 vaccines and therapeutics
- Cell and gene therapy share of medicine spending 1 cell and gene therapy
- Cell and gene therapy spending 1 cell and gene therapy
- Cell and gene therapy spending average annual growth rate 1 cell and gene therapy
- Cell and gene therapy spending growth rate 1 cell and gene therapy
- Cell and gene therapy spending year-over-year growth 1 cell and gene therapy
- GIP/GLP-1 agonist spending growth contribution 1 gip glp 1 agonist
- Innovative medicines spending target share of GDP 1 innovative
Frequently asked questions
What is the latest high GDP developed countries medicine spending growth?
Global: 155.1 billion constant USD in 2026–2030.
Where does this data come from?
From 1 document published by IQVIA. Every figure on this page links to its record, which preserves the original source evidence.
How often is it updated?
Irregularly: the publishers behind this measure do not release it on a fixed schedule. A new figure appears here once it is published and verified.
Can I use this data?
Yes. StatOrigin publishes it under CC BY 4.0: you may copy, chart and republish it, including commercially, with attribution to StatOrigin and to the original publisher.
Cite this page
Cite the page as a data set, or open any record to cite one figure: each record carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). High GDP developed countries medicine spending growth [Data set]. Retrieved October 28, 2026, from https://statorigin.org/indicators/high-gdp-developed-countries-medicine-spending-growth
"High GDP developed countries medicine spending growth." StatOrigin, 2026, https://statorigin.org/indicators/high-gdp-developed-countries-medicine-spending-growth. Accessed 28 Oct. 2026.
StatOrigin. "High GDP developed countries medicine spending growth." Data set, 2026. Accessed October 28, 2026. https://statorigin.org/indicators/high-gdp-developed-countries-medicine-spending-growth.
@misc{statorigin_high_gdp_developed_countries_medicine_spending_growth_2026, title = {High GDP developed countries medicine spending growth}, author = {{StatOrigin}}, year = {2026}, url = {https://statorigin.org/indicators/high-gdp-developed-countries-medicine-spending-growth}, note = {Data set. Accessed 2026-10-28} }